Watchman FLX Left Atrial Appendage Closure Device Post Approval Study (

See also
Status	Clinical Trial	Phase
Completed	`NCT02502396` - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Withdrawn	`NCT03508258` - Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)
Terminated	`NCT03715725` - A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.
Active, not recruiting	`NCT05565599` - An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation	N/A
Completed	`NCT02756481` - Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela	N/A
Completed	`NCT04193826` - The Conformal Prague Study	N/A
Completed	`NCT01884350` - Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)	Phase 4
Completed	`NCT02422602` - Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program	N/A
Recruiting	`NCT02147444` - Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation	N/A
Completed	`NCT01857622` - Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment	Phase 3
Recruiting	`NCT04829929` - Evaluation od Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk	N/A
Recruiting	`NCT05761704` - Exploratory Observation of Two Short-term Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With Non-valvular Atrial Fibrillation	N/A
Recruiting	`NCT04559243` - Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
Completed	`NCT03570047` - Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
Terminated	`NCT03204695` - WAVECREST Post Market Clinical Follow-Up (PMCF) Study	N/A
Completed	`NCT04722679` - A Study to Collect Information on the Characteristics of Elderly Belgian Patients With NVAF That Are Treated With a NOAC for This Indication With a Special Focus on Their Fear of Bleeding While Using a NOAC vs the Clinical Benefit of a NOAC of Thrombosis/Stroke Prevention.
Completed	`NCT04297072` - Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists
Recruiting	`NCT05320627` - Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation	Phase 4
Recruiting	`NCT03088072` - A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure	Phase 4
Completed	`NCT04519944` - Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

NCT number	NCT02654470
Study type	Observational
Source	Boston Scientific Corporation
Contact
Status	Completed
Phase
Start date	July 16, 2019
Completion date	September 28, 2021

Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms